• OPEN AN ACCOUNT
Indian Indices
Sensex
76,933.59 -539.35
( -0.70%)
Global Indices
Nasdaq
53,487.87 -110.53
(-0.21%)
Dow Jones
7,697.38 -0.90
(-0.01%)
Hang Seng
66,058.92 -203.24
(-0.31%)
Nikkei 225
10,795.58 -82.54
(-0.76%)
Forex
USD-INR
95.31 -0.39
(-0.41%)
EUR-INR
111.19 -0.48
(-0.43%)
GBP-INR
129.97 -0.53
(-0.40%)
JPY-INR
0.60 0.00
(-0.54%)

EQUITY - MARKET SCREENER

RBM Infracon Ltd
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
77929
INE0NA301016
176.4628985
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
RBMINFRA
5.76
260.88
EPS(TTM)
Face Value()
Div & Yield %
42.59
10
0
 

Bafna Pharmaceuticals standalone net profit rises 109.92% in the March 2026 quarter
May 30,2026
Net profit of Bafna Pharmaceuticals rose 109.92% to Rs 2.75 crore in the quarter ended March 2026 as against Rs 1.31 crore during the previous quarter ended March 2025. Sales rose 8.14% to Rs 42.24 crore in the quarter ended March 2026 as against Rs 39.06 crore during the previous quarter ended March 2025.

For the full year,net profit rose 167.47% to Rs 11.10 crore in the year ended March 2026 as against Rs 4.15 crore during the previous year ended March 2025. Sales rose 3.26% to Rs 150.62 crore in the year ended March 2026 as against Rs 145.86 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales42.2439.06 8 150.62145.86 3
OPM %8.407.96 -10.587.66 -
PBDT4.283.32 29 17.0411.19 52
PBT2.623.10 -15 10.976.30 74
NP2.751.31 110 11.104.15 167